Gain-of-function mutations in fibroblast growth factor receptors have been
identified in numerous syndromes associated with premature cranial suture f
usion. Murine models in which the posterior frontal suture undergoes progra
mmed fusion after birth while all other sutures remain patent provide an id
eal model to study the biomolecular mechanisms that govern cranial suture f
usion, Using adenoviral vectors and targeted in utero injections in rats, w
e demonstrate that physiological posterior frontal suture fusion is inhibit
ed using a dominant-negative fibroblast growth factor receptor-1 construct,
whereas the normally patent coronal suture fuses when infected with a cons
truct that increases basic fibroblast growth factor biological activity. Ou
r data may facilitate the development of novel, less invasive treatment opt
ions for children with craniosynostosis.